Nicorette Freshmint (Nicotine)

Nicotine, the active ingredient in Nicorette Freshmint, is a nicotine replacement therapy presented as a lozenge for oromucosal use. It assists adult smokers in quitting by reducing withdrawal symptoms, cravings, and the urge to smoke, supporting a gradual transition away from tobacco dependence.

GNH USA supplies Nicorette Freshmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals, and clinics worldwide, ensuring quality compliance with EU standards and reliable distribution channels. Our network includes procurement teams and regulatory support for seamless import and local market integration.

Nicorette Freshmint, a nicotine replacement therapy, is used in the management of nicotine dependence.

Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms when quitting tobacco use. Tobacco dependence: supports gradual reduction of nicotine intake as part of a structured quit plan. Relapse prevention: assists former smokers who are at risk of returning to smoking by providing controlled nicotine delivery.

Nicorette Freshmint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: soreness or tingling in the mouth or throat. - Nausea: feeling of queasiness or upset stomach. - Hiccups: involuntary diaphragm contractions after use. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain: unexpected discomfort in the chest area. - Rapid heart rate: palpitations or tachycardia.

When using Nicorette Freshmint, consider the following precautions to ensure safe and effective use.

Contraindication: avoid use in individuals with known hypersensitivity to nicotine or product ingredients. Cardiovascular disease: use with caution in patients with recent heart attack, uncontrolled hypertension, or arrhythmias. Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. Age restriction: not recommended for children or adolescents under 18 years of age. Medication interactions: review concomitant drugs that may affect nicotine metabolism or cardiovascular status. Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Nicotine can interact with several medicines, influencing their effects or increasing risk of adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may cause hypertensive crisis. - Other nicotine products: using multiple sources can lead to nicotine overdose.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase plasma nicotine levels, requiring monitoring. - Beta‑blockers: nicotine may reduce their antihypertensive efficacy. - Antipsychotics (e.g., clozapine): nicotine can alter drug metabolism, affecting plasma concentrations.